<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>1363</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>15115181</PubmedId>
            <Abstract>Previously, we mapped the antibody (Ab) and T-cell recognition regions on the HC domain (residues 855-1296) of the 848-residue heavy (H) chain of botulinum neurotoxin A (BoNT/A). We have mapped here the HN-domain (residues 449-859) regions that bind protective anti-BoNT/A Abs raised in four different species. We synthesized, purified, and characterized 29 19-residue peptides that spanned the entire HN and overlapped consecutively by 5 residues, and also region L218-231 around the L-chain's substrate-binding site. Human, horse, mouse, and chicken anti-BoNT/A Abs did not bind to the L-peptide but recognized similar HN regions within peptides 519-537/533-551/547-565/561-579 (with slight left- or right-shifts), 743-761, 785-803, and 813-831/827-845 overlap. Recognition of other peptides that bound lower Ab levels showed similarities and also some differences. Peptide 463-481, strongly immunodominant with horse antisera, did not bind human, mouse, and chicken Abs. However, peptide 449-467 bound Abs in these three antisera, and the region may have shifted to the right (peptide 463-481) with horse Abs. The overlap 659-677/673-691 reacted strongly with human Abs whereas with mouse and chicken antisera, only peptide 673-691 showed low reactivity. Horse antisera had no detectable Ab binding to region(s) 659-691. The Ab-recognition regions on the H chain occupy surface locations in BoNT/A three-dimensional structure, but the great part of the surface is not immunogenic. Regions recognized by the protective antisera of the four different species are prime candidates for inclusion in synthetic vaccine designs.</Abstract>
            <ArticleYear>2004</ArticleYear>
            <ArticlePages>39-52</ArticlePages>
            <ArticleTitle>Mapping of the antibody-binding regions on the HN-domain (residues 449-859) of botulinum neurotoxin A with antitoxin antibodies from four host species. Full profile of the continuous antigenic regions of the H-chain of botulinum neurotoxin A.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Atassi</LastName>
                    <ForeName>M Zouhair</ForeName>
                </Author>
                <Author>
                    <LastName>Dolimbek</LastName>
                    <ForeName>Behzod Z</ForeName>
                </Author>
            </Authors>
            <Affiliations>Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas, USA. matassi@bcm.tmc.edu.</Affiliations>
            <ArticleChemicalList>Antibodies, Bacterial;Bacterial Vaccines;Epitopes;Neuromuscular Agents;Peptides;Botulinum Toxins, Type A</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Animals; Antibodies, Bacterial(immunology); Antibody Specificity; Bacterial Vaccines; Botulinum Toxins, Type A(immunology); Chickens; Clostridium botulinum(immunology); Epitope Mapping; Epitopes(genetics; immunology); Horses; Humans; Mice; Molecular Sequence Data; Neuromuscular Agents(immunology); Peptides(genetics; immunology); Protein Structure, Tertiary; Species Specificity</ArticleMeshHeadingsList>
            <Journal>
                <Volume>23</Volume>
                <Issue>1</Issue>
                <Title>The protein journal.</Title>
                <Issn>1572-3887</Issn>
                <MedlineTa>Protein J</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>L-peptide</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>AVTLAHELIHAGHR</LinearSequence>
                        <StartingPosition>218</StartingPosition>
                        <EndingPosition>231</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>5564</EpitopeId>
                <ReferenceStartingPosition>218</ReferenceStartingPosition>
                <ReferenceEndingPosition>231</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>21405</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>L-peptide</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>AVTLAHELIHAGHR</LinearSequence>
                                        <StartingPosition>218</StartingPosition>
                                        <EndingPosition>231</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>21397</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>L-peptide</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>AVTLAHELIHAGHR</LinearSequence>
                                        <StartingPosition>218</StartingPosition>
                                        <EndingPosition>231</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>21394</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>L-peptide</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>AVTLAHELIHAGHR</LinearSequence>
                                        <StartingPosition>218</StartingPosition>
                                        <EndingPosition>231</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>21371</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>L-peptide</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>AVTLAHELIHAGHR</LinearSequence>
                                        <StartingPosition>218</StartingPosition>
                                        <EndingPosition>231</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>N1</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>ALNDLCIKVNNWDLFFSPS</LinearSequence>
                        <StartingPosition>449</StartingPosition>
                        <EndingPosition>467</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>2772</EpitopeId>
                <ReferenceStartingPosition>449</ReferenceStartingPosition>
                <ReferenceEndingPosition>467</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>21417</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>15000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N1</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ALNDLCIKVNNWDLFFSPS</LinearSequence>
                                        <StartingPosition>449</StartingPosition>
                                        <EndingPosition>467</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>21418</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N1</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ALNDLCIKVNNWDLFFSPS</LinearSequence>
                                        <StartingPosition>449</StartingPosition>
                                        <EndingPosition>467</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>21419</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N1</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ALNDLCIKVNNWDLFFSPS</LinearSequence>
                                        <StartingPosition>449</StartingPosition>
                                        <EndingPosition>467</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>21420</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>3000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N1</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ALNDLCIKVNNWDLFFSPS</LinearSequence>
                                        <StartingPosition>449</StartingPosition>
                                        <EndingPosition>467</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>N2</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>FFSPSEDNFTNDLNKGEEI</LinearSequence>
                        <StartingPosition>463</StartingPosition>
                        <EndingPosition>481</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>15900</EpitopeId>
                <ReferenceStartingPosition>463</ReferenceStartingPosition>
                <ReferenceEndingPosition>481</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>21423</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N2</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>FFSPSEDNFTNDLNKGEEI</LinearSequence>
                                        <StartingPosition>463</StartingPosition>
                                        <EndingPosition>481</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>21421</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N2</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>FFSPSEDNFTNDLNKGEEI</LinearSequence>
                                        <StartingPosition>463</StartingPosition>
                                        <EndingPosition>481</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>21422</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>35000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N2</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>FFSPSEDNFTNDLNKGEEI</LinearSequence>
                                        <StartingPosition>463</StartingPosition>
                                        <EndingPosition>481</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>21424</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N2</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>FFSPSEDNFTNDLNKGEEI</LinearSequence>
                                        <StartingPosition>463</StartingPosition>
                                        <EndingPosition>481</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>N3</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KGEEITSDTNIEAAEENIS</LinearSequence>
                        <StartingPosition>477</StartingPosition>
                        <EndingPosition>495</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>30918</EpitopeId>
                <ReferenceStartingPosition>477</ReferenceStartingPosition>
                <ReferenceEndingPosition>495</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>21428</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N3</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KGEEITSDTNIEAAEENIS</LinearSequence>
                                        <StartingPosition>477</StartingPosition>
                                        <EndingPosition>495</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>21427</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>3000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N3</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KGEEITSDTNIEAAEENIS</LinearSequence>
                                        <StartingPosition>477</StartingPosition>
                                        <EndingPosition>495</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>21429</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N3</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KGEEITSDTNIEAAEENIS</LinearSequence>
                                        <StartingPosition>477</StartingPosition>
                                        <EndingPosition>495</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>21426</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N3</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KGEEITSDTNIEAAEENIS</LinearSequence>
                                        <StartingPosition>477</StartingPosition>
                                        <EndingPosition>495</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>N4</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>EENISLDLIQQYYLTFNFD</LinearSequence>
                        <StartingPosition>491</StartingPosition>
                        <EndingPosition>509</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>11800</EpitopeId>
                <ReferenceStartingPosition>491</ReferenceStartingPosition>
                <ReferenceEndingPosition>509</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>21432</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>3000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N4</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EENISLDLIQQYYLTFNFD</LinearSequence>
                                        <StartingPosition>491</StartingPosition>
                                        <EndingPosition>509</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>21431</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N4</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EENISLDLIQQYYLTFNFD</LinearSequence>
                                        <StartingPosition>491</StartingPosition>
                                        <EndingPosition>509</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>21430</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>15000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N4</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EENISLDLIQQYYLTFNFD</LinearSequence>
                                        <StartingPosition>491</StartingPosition>
                                        <EndingPosition>509</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>21433</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N4</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EENISLDLIQQYYLTFNFD</LinearSequence>
                                        <StartingPosition>491</StartingPosition>
                                        <EndingPosition>509</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>N5</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>TFNFDNEPENISIENLSSD</LinearSequence>
                        <StartingPosition>505</StartingPosition>
                        <EndingPosition>523</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>63715</EpitopeId>
                <ReferenceStartingPosition>505</ReferenceStartingPosition>
                <ReferenceEndingPosition>523</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>21437</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N5</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TFNFDNEPENISIENLSSD</LinearSequence>
                                        <StartingPosition>505</StartingPosition>
                                        <EndingPosition>523</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>21435</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N5</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TFNFDNEPENISIENLSSD</LinearSequence>
                                        <StartingPosition>505</StartingPosition>
                                        <EndingPosition>523</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>21436</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N5</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TFNFDNEPENISIENLSSD</LinearSequence>
                                        <StartingPosition>505</StartingPosition>
                                        <EndingPosition>523</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>21434</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N5</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TFNFDNEPENISIENLSSD</LinearSequence>
                                        <StartingPosition>505</StartingPosition>
                                        <EndingPosition>523</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>N6</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>NLSSDIIGQLELMPNIERF</LinearSequence>
                        <StartingPosition>519</StartingPosition>
                        <EndingPosition>537</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>44880</EpitopeId>
                <ReferenceStartingPosition>519</ReferenceStartingPosition>
                <ReferenceEndingPosition>537</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>21440</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>25000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N6</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NLSSDIIGQLELMPNIERF</LinearSequence>
                                        <StartingPosition>519</StartingPosition>
                                        <EndingPosition>537</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>21441</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>15000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N6</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NLSSDIIGQLELMPNIERF</LinearSequence>
                                        <StartingPosition>519</StartingPosition>
                                        <EndingPosition>537</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>21439</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N6</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NLSSDIIGQLELMPNIERF</LinearSequence>
                                        <StartingPosition>519</StartingPosition>
                                        <EndingPosition>537</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>21438</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>15000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N6</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NLSSDIIGQLELMPNIERF</LinearSequence>
                                        <StartingPosition>519</StartingPosition>
                                        <EndingPosition>537</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>N7</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>NIERFPNGKKYELDKYTMF</LinearSequence>
                        <StartingPosition>533</StartingPosition>
                        <EndingPosition>551</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>44218</EpitopeId>
                <ReferenceStartingPosition>533</ReferenceStartingPosition>
                <ReferenceEndingPosition>551</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>21444</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>25000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N7</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NIERFPNGKKYELDKYTMF</LinearSequence>
                                        <StartingPosition>533</StartingPosition>
                                        <EndingPosition>551</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>21445</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>25000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N7</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NIERFPNGKKYELDKYTMF</LinearSequence>
                                        <StartingPosition>533</StartingPosition>
                                        <EndingPosition>551</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>21442</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>15000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N7</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NIERFPNGKKYELDKYTMF</LinearSequence>
                                        <StartingPosition>533</StartingPosition>
                                        <EndingPosition>551</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>21443</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>25000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N7</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NIERFPNGKKYELDKYTMF</LinearSequence>
                                        <StartingPosition>533</StartingPosition>
                                        <EndingPosition>551</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>N8</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KYTMFHYLRAQEFEHGKSR</LinearSequence>
                        <StartingPosition>547</StartingPosition>
                        <EndingPosition>565</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>34612</EpitopeId>
                <ReferenceStartingPosition>547</ReferenceStartingPosition>
                <ReferenceEndingPosition>565</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>21447</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>35000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N8</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KYTMFHYLRAQEFEHGKSR</LinearSequence>
                                        <StartingPosition>547</StartingPosition>
                                        <EndingPosition>565</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>21449</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>35000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N8</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KYTMFHYLRAQEFEHGKSR</LinearSequence>
                                        <StartingPosition>547</StartingPosition>
                                        <EndingPosition>565</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>21448</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>35000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N8</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KYTMFHYLRAQEFEHGKSR</LinearSequence>
                                        <StartingPosition>547</StartingPosition>
                                        <EndingPosition>565</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>21446</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>35000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N8</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KYTMFHYLRAQEFEHGKSR</LinearSequence>
                                        <StartingPosition>547</StartingPosition>
                                        <EndingPosition>565</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>N9</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>HGKSRIALTNSVNEALLNP</LinearSequence>
                        <StartingPosition>561</StartingPosition>
                        <EndingPosition>579</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>23919</EpitopeId>
                <ReferenceStartingPosition>561</ReferenceStartingPosition>
                <ReferenceEndingPosition>579</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>21452</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>35000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N9</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>HGKSRIALTNSVNEALLNP</LinearSequence>
                                        <StartingPosition>561</StartingPosition>
                                        <EndingPosition>579</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>21451</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>35000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N9</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>HGKSRIALTNSVNEALLNP</LinearSequence>
                                        <StartingPosition>561</StartingPosition>
                                        <EndingPosition>579</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>21453</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>3000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N9</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>HGKSRIALTNSVNEALLNP</LinearSequence>
                                        <StartingPosition>561</StartingPosition>
                                        <EndingPosition>579</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>21450</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N9</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>HGKSRIALTNSVNEALLNP</LinearSequence>
                                        <StartingPosition>561</StartingPosition>
                                        <EndingPosition>579</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>N10</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>ALLNPSRVYTFFSSDYVKK</LinearSequence>
                        <StartingPosition>575</StartingPosition>
                        <EndingPosition>593</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>2720</EpitopeId>
                <ReferenceStartingPosition>575</ReferenceStartingPosition>
                <ReferenceEndingPosition>593</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>21454</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>3000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N10</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ALLNPSRVYTFFSSDYVKK</LinearSequence>
                                        <StartingPosition>575</StartingPosition>
                                        <EndingPosition>593</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>21456</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N10</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ALLNPSRVYTFFSSDYVKK</LinearSequence>
                                        <StartingPosition>575</StartingPosition>
                                        <EndingPosition>593</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>21457</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>15000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N10</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ALLNPSRVYTFFSSDYVKK</LinearSequence>
                                        <StartingPosition>575</StartingPosition>
                                        <EndingPosition>593</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>21455</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>15000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N10</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ALLNPSRVYTFFSSDYVKK</LinearSequence>
                                        <StartingPosition>575</StartingPosition>
                                        <EndingPosition>593</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>N11</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>DYVKKVNKATEAAMFLGWV</LinearSequence>
                        <StartingPosition>589</StartingPosition>
                        <EndingPosition>607</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>10975</EpitopeId>
                <ReferenceStartingPosition>589</ReferenceStartingPosition>
                <ReferenceEndingPosition>607</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>21458</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>25000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N11</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>DYVKKVNKATEAAMFLGWV</LinearSequence>
                                        <StartingPosition>589</StartingPosition>
                                        <EndingPosition>607</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>21461</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N11</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>DYVKKVNKATEAAMFLGWV</LinearSequence>
                                        <StartingPosition>589</StartingPosition>
                                        <EndingPosition>607</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>21459</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N11</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>DYVKKVNKATEAAMFLGWV</LinearSequence>
                                        <StartingPosition>589</StartingPosition>
                                        <EndingPosition>607</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>21460</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N11</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>DYVKKVNKATEAAMFLGWV</LinearSequence>
                                        <StartingPosition>589</StartingPosition>
                                        <EndingPosition>607</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>N12</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>FLGWVEQLVYDFTDETSEV</LinearSequence>
                        <StartingPosition>603</StartingPosition>
                        <EndingPosition>621</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>16635</EpitopeId>
                <ReferenceStartingPosition>603</ReferenceStartingPosition>
                <ReferenceEndingPosition>621</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>21465</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N12</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>FLGWVEQLVYDFTDETSEV</LinearSequence>
                                        <StartingPosition>603</StartingPosition>
                                        <EndingPosition>621</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>21462</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N12</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>FLGWVEQLVYDFTDETSEV</LinearSequence>
                                        <StartingPosition>603</StartingPosition>
                                        <EndingPosition>621</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>21463</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N12</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>FLGWVEQLVYDFTDETSEV</LinearSequence>
                                        <StartingPosition>603</StartingPosition>
                                        <EndingPosition>621</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>21464</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N12</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>FLGWVEQLVYDFTDETSEV</LinearSequence>
                                        <StartingPosition>603</StartingPosition>
                                        <EndingPosition>621</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>N13</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>ETSEVSTTDKIADITIIIP</LinearSequence>
                        <StartingPosition>617</StartingPosition>
                        <EndingPosition>635</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>14540</EpitopeId>
                <ReferenceStartingPosition>617</ReferenceStartingPosition>
                <ReferenceEndingPosition>635</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>21466</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N13</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ETSEVSTTDKIADITIIIP</LinearSequence>
                                        <StartingPosition>617</StartingPosition>
                                        <EndingPosition>635</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>21468</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N13</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ETSEVSTTDKIADITIIIP</LinearSequence>
                                        <StartingPosition>617</StartingPosition>
                                        <EndingPosition>635</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>21469</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N13</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ETSEVSTTDKIADITIIIP</LinearSequence>
                                        <StartingPosition>617</StartingPosition>
                                        <EndingPosition>635</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>21467</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>3000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N13</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ETSEVSTTDKIADITIIIP</LinearSequence>
                                        <StartingPosition>617</StartingPosition>
                                        <EndingPosition>635</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>N14</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>TIIIPYIGPALNIGNMLYK</LinearSequence>
                        <StartingPosition>631</StartingPosition>
                        <EndingPosition>649</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>64328</EpitopeId>
                <ReferenceStartingPosition>631</ReferenceStartingPosition>
                <ReferenceEndingPosition>649</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>21470</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>15000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N14</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TIIIPYIGPALNIGNMLYK</LinearSequence>
                                        <StartingPosition>631</StartingPosition>
                                        <EndingPosition>649</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>21471</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>3000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N14</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TIIIPYIGPALNIGNMLYK</LinearSequence>
                                        <StartingPosition>631</StartingPosition>
                                        <EndingPosition>649</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>21472</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>3000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N14</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TIIIPYIGPALNIGNMLYK</LinearSequence>
                                        <StartingPosition>631</StartingPosition>
                                        <EndingPosition>649</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>21473</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N14</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TIIIPYIGPALNIGNMLYK</LinearSequence>
                                        <StartingPosition>631</StartingPosition>
                                        <EndingPosition>649</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>N15</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>NMLYKDDFVGALIFSGAVI</LinearSequence>
                        <StartingPosition>645</StartingPosition>
                        <EndingPosition>663</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>45003</EpitopeId>
                <ReferenceStartingPosition>645</ReferenceStartingPosition>
                <ReferenceEndingPosition>663</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>21475</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N15</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NMLYKDDFVGALIFSGAVI</LinearSequence>
                                        <StartingPosition>645</StartingPosition>
                                        <EndingPosition>663</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>21474</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N15</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NMLYKDDFVGALIFSGAVI</LinearSequence>
                                        <StartingPosition>645</StartingPosition>
                                        <EndingPosition>663</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>21476</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N15</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NMLYKDDFVGALIFSGAVI</LinearSequence>
                                        <StartingPosition>645</StartingPosition>
                                        <EndingPosition>663</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>21477</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>3000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N15</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NMLYKDDFVGALIFSGAVI</LinearSequence>
                                        <StartingPosition>645</StartingPosition>
                                        <EndingPosition>663</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>N16</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SGAVILLEFIPEIAIPVLG</LinearSequence>
                        <StartingPosition>659</StartingPosition>
                        <EndingPosition>677</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>57988</EpitopeId>
                <ReferenceStartingPosition>659</ReferenceStartingPosition>
                <ReferenceEndingPosition>677</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>21480</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N16</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SGAVILLEFIPEIAIPVLG</LinearSequence>
                                        <StartingPosition>659</StartingPosition>
                                        <EndingPosition>677</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>21481</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N16</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SGAVILLEFIPEIAIPVLG</LinearSequence>
                                        <StartingPosition>659</StartingPosition>
                                        <EndingPosition>677</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>21478</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>35000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N16</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SGAVILLEFIPEIAIPVLG</LinearSequence>
                                        <StartingPosition>659</StartingPosition>
                                        <EndingPosition>677</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>21479</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N16</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SGAVILLEFIPEIAIPVLG</LinearSequence>
                                        <StartingPosition>659</StartingPosition>
                                        <EndingPosition>677</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>N17</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>IPVLGTFALVSYIANKVLT</LinearSequence>
                        <StartingPosition>673</StartingPosition>
                        <EndingPosition>691</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>28105</EpitopeId>
                <ReferenceStartingPosition>673</ReferenceStartingPosition>
                <ReferenceEndingPosition>691</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>21482</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>15000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N17</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>IPVLGTFALVSYIANKVLT</LinearSequence>
                                        <StartingPosition>673</StartingPosition>
                                        <EndingPosition>691</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>21484</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>3000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N17</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>IPVLGTFALVSYIANKVLT</LinearSequence>
                                        <StartingPosition>673</StartingPosition>
                                        <EndingPosition>691</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>21483</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N17</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>IPVLGTFALVSYIANKVLT</LinearSequence>
                                        <StartingPosition>673</StartingPosition>
                                        <EndingPosition>691</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>21485</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>15000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N17</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>IPVLGTFALVSYIANKVLT</LinearSequence>
                                        <StartingPosition>673</StartingPosition>
                                        <EndingPosition>691</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>N18</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>NKVLTVQTIDNALSKRNEK</LinearSequence>
                        <StartingPosition>687</StartingPosition>
                        <EndingPosition>705</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>44619</EpitopeId>
                <ReferenceStartingPosition>687</ReferenceStartingPosition>
                <ReferenceEndingPosition>705</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>21487</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>3000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N18</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NKVLTVQTIDNALSKRNEK</LinearSequence>
                                        <StartingPosition>687</StartingPosition>
                                        <EndingPosition>705</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>21489</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N18</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NKVLTVQTIDNALSKRNEK</LinearSequence>
                                        <StartingPosition>687</StartingPosition>
                                        <EndingPosition>705</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>21488</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N18</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NKVLTVQTIDNALSKRNEK</LinearSequence>
                                        <StartingPosition>687</StartingPosition>
                                        <EndingPosition>705</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>21486</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N18</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NKVLTVQTIDNALSKRNEK</LinearSequence>
                                        <StartingPosition>687</StartingPosition>
                                        <EndingPosition>705</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>N19</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KRNEKWDEVYKYIVTNWLA</LinearSequence>
                        <StartingPosition>701</StartingPosition>
                        <EndingPosition>719</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>33198</EpitopeId>
                <ReferenceStartingPosition>701</ReferenceStartingPosition>
                <ReferenceEndingPosition>719</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>21490</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>3000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N19</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KRNEKWDEVYKYIVTNWLA</LinearSequence>
                                        <StartingPosition>701</StartingPosition>
                                        <EndingPosition>719</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>21493</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>15000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N19</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KRNEKWDEVYKYIVTNWLA</LinearSequence>
                                        <StartingPosition>701</StartingPosition>
                                        <EndingPosition>719</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>21491</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N19</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KRNEKWDEVYKYIVTNWLA</LinearSequence>
                                        <StartingPosition>701</StartingPosition>
                                        <EndingPosition>719</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>21492</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N19</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KRNEKWDEVYKYIVTNWLA</LinearSequence>
                                        <StartingPosition>701</StartingPosition>
                                        <EndingPosition>719</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>N20</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>TNWLAKVNTQIDLIRKKMK</LinearSequence>
                        <StartingPosition>715</StartingPosition>
                        <EndingPosition>733</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>65481</EpitopeId>
                <ReferenceStartingPosition>715</ReferenceStartingPosition>
                <ReferenceEndingPosition>733</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>21494</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>15000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N20</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TNWLAKVNTQIDLIRKKMK</LinearSequence>
                                        <StartingPosition>715</StartingPosition>
                                        <EndingPosition>733</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>21496</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>3000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N20</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TNWLAKVNTQIDLIRKKMK</LinearSequence>
                                        <StartingPosition>715</StartingPosition>
                                        <EndingPosition>733</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>21497</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>15000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N20</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TNWLAKVNTQIDLIRKKMK</LinearSequence>
                                        <StartingPosition>715</StartingPosition>
                                        <EndingPosition>733</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>21495</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>15000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N20</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TNWLAKVNTQIDLIRKKMK</LinearSequence>
                                        <StartingPosition>715</StartingPosition>
                                        <EndingPosition>733</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>N21</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>RKKMKEALENQAEATKAII</LinearSequence>
                        <StartingPosition>729</StartingPosition>
                        <EndingPosition>747</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>54378</EpitopeId>
                <ReferenceStartingPosition>729</ReferenceStartingPosition>
                <ReferenceEndingPosition>747</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>21498</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>3000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N21</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>RKKMKEALENQAEATKAII</LinearSequence>
                                        <StartingPosition>729</StartingPosition>
                                        <EndingPosition>747</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>21500</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N21</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>RKKMKEALENQAEATKAII</LinearSequence>
                                        <StartingPosition>729</StartingPosition>
                                        <EndingPosition>747</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>21501</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N21</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>RKKMKEALENQAEATKAII</LinearSequence>
                                        <StartingPosition>729</StartingPosition>
                                        <EndingPosition>747</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>21499</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N21</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>RKKMKEALENQAEATKAII</LinearSequence>
                                        <StartingPosition>729</StartingPosition>
                                        <EndingPosition>747</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>N22</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>TKAIINYQYNQYTEEEKNN</LinearSequence>
                        <StartingPosition>743</StartingPosition>
                        <EndingPosition>761</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>64525</EpitopeId>
                <ReferenceStartingPosition>743</ReferenceStartingPosition>
                <ReferenceEndingPosition>761</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>21502</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>35000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N22</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TKAIINYQYNQYTEEEKNN</LinearSequence>
                                        <StartingPosition>743</StartingPosition>
                                        <EndingPosition>761</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>21504</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N22</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TKAIINYQYNQYTEEEKNN</LinearSequence>
                                        <StartingPosition>743</StartingPosition>
                                        <EndingPosition>761</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>21503</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>15000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N22</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TKAIINYQYNQYTEEEKNN</LinearSequence>
                                        <StartingPosition>743</StartingPosition>
                                        <EndingPosition>761</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>21505</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>35000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N22</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TKAIINYQYNQYTEEEKNN</LinearSequence>
                                        <StartingPosition>743</StartingPosition>
                                        <EndingPosition>761</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>N23</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>EEKNNINFNIDDLSSKLNE</LinearSequence>
                        <StartingPosition>757</StartingPosition>
                        <EndingPosition>775</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>11729</EpitopeId>
                <ReferenceStartingPosition>757</ReferenceStartingPosition>
                <ReferenceEndingPosition>775</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>21507</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N23</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EEKNNINFNIDDLSSKLNE</LinearSequence>
                                        <StartingPosition>757</StartingPosition>
                                        <EndingPosition>775</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>21509</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N23</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EEKNNINFNIDDLSSKLNE</LinearSequence>
                                        <StartingPosition>757</StartingPosition>
                                        <EndingPosition>775</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>21506</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N23</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EEKNNINFNIDDLSSKLNE</LinearSequence>
                                        <StartingPosition>757</StartingPosition>
                                        <EndingPosition>775</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>21508</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N23</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EEKNNINFNIDDLSSKLNE</LinearSequence>
                                        <StartingPosition>757</StartingPosition>
                                        <EndingPosition>775</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>N24</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SKLNESINKAMININKFLN</LinearSequence>
                        <StartingPosition>771</StartingPosition>
                        <EndingPosition>789</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>58886</EpitopeId>
                <ReferenceStartingPosition>771</ReferenceStartingPosition>
                <ReferenceEndingPosition>789</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>22805</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>15000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N24</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SKLNESINKAMININKFLN</LinearSequence>
                                        <StartingPosition>771</StartingPosition>
                                        <EndingPosition>789</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>22806</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>3000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N24</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SKLNESINKAMININKFLN</LinearSequence>
                                        <StartingPosition>771</StartingPosition>
                                        <EndingPosition>789</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>22807</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N24</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SKLNESINKAMININKFLN</LinearSequence>
                                        <StartingPosition>771</StartingPosition>
                                        <EndingPosition>789</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>22808</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N24</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SKLNESINKAMININKFLN</LinearSequence>
                                        <StartingPosition>771</StartingPosition>
                                        <EndingPosition>789</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>N25</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>NKFLNQCSVSYLMNSMIPY</LinearSequence>
                        <StartingPosition>785</StartingPosition>
                        <EndingPosition>803</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>44491</EpitopeId>
                <ReferenceStartingPosition>785</ReferenceStartingPosition>
                <ReferenceEndingPosition>803</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>22812</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>35000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N25</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NKFLNQCSVSYLMNSMIPY</LinearSequence>
                                        <StartingPosition>785</StartingPosition>
                                        <EndingPosition>803</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>22811</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>35000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N25</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NKFLNQCSVSYLMNSMIPY</LinearSequence>
                                        <StartingPosition>785</StartingPosition>
                                        <EndingPosition>803</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>22810</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>25000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N25</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NKFLNQCSVSYLMNSMIPY</LinearSequence>
                                        <StartingPosition>785</StartingPosition>
                                        <EndingPosition>803</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>22809</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>35000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N25</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NKFLNQCSVSYLMNSMIPY</LinearSequence>
                                        <StartingPosition>785</StartingPosition>
                                        <EndingPosition>803</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>N26</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SMIPYGVKRLEDFDASLKD</LinearSequence>
                        <StartingPosition>799</StartingPosition>
                        <EndingPosition>817</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>59685</EpitopeId>
                <ReferenceStartingPosition>799</ReferenceStartingPosition>
                <ReferenceEndingPosition>817</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>22813</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N26</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SMIPYGVKRLEDFDASLKD</LinearSequence>
                                        <StartingPosition>799</StartingPosition>
                                        <EndingPosition>817</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>22814</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N26</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SMIPYGVKRLEDFDASLKD</LinearSequence>
                                        <StartingPosition>799</StartingPosition>
                                        <EndingPosition>817</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>22815</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N26</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SMIPYGVKRLEDFDASLKD</LinearSequence>
                                        <StartingPosition>799</StartingPosition>
                                        <EndingPosition>817</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>22816</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N26</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SMIPYGVKRLEDFDASLKD</LinearSequence>
                                        <StartingPosition>799</StartingPosition>
                                        <EndingPosition>817</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>N27</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>ASLKDALLKYIYDNRGTLI</LinearSequence>
                        <StartingPosition>813</StartingPosition>
                        <EndingPosition>831</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>4528</EpitopeId>
                <ReferenceStartingPosition>813</ReferenceStartingPosition>
                <ReferenceEndingPosition>831</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>22819</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>25000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N27</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ASLKDALLKYIYDNRGTLI</LinearSequence>
                                        <StartingPosition>813</StartingPosition>
                                        <EndingPosition>831</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>22817</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>15000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N27</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ASLKDALLKYIYDNRGTLI</LinearSequence>
                                        <StartingPosition>813</StartingPosition>
                                        <EndingPosition>831</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>22818</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>35000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N27</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ASLKDALLKYIYDNRGTLI</LinearSequence>
                                        <StartingPosition>813</StartingPosition>
                                        <EndingPosition>831</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>22820</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>35000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N27</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ASLKDALLKYIYDNRGTLI</LinearSequence>
                                        <StartingPosition>813</StartingPosition>
                                        <EndingPosition>831</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>N28</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>RGTLIGQVDRLKDKVNNTL</LinearSequence>
                        <StartingPosition>827</StartingPosition>
                        <EndingPosition>845</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>53998</EpitopeId>
                <ReferenceStartingPosition>827</ReferenceStartingPosition>
                <ReferenceEndingPosition>845</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>22823</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>25000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N28</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>RGTLIGQVDRLKDKVNNTL</LinearSequence>
                                        <StartingPosition>827</StartingPosition>
                                        <EndingPosition>845</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>22822</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N28</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>RGTLIGQVDRLKDKVNNTL</LinearSequence>
                                        <StartingPosition>827</StartingPosition>
                                        <EndingPosition>845</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>22824</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>25000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N28</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>RGTLIGQVDRLKDKVNNTL</LinearSequence>
                                        <StartingPosition>827</StartingPosition>
                                        <EndingPosition>845</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>22821</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>15000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N28</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>RGTLIGQVDRLKDKVNNTL</LinearSequence>
                                        <StartingPosition>827</StartingPosition>
                                        <EndingPosition>845</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>N29</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>VNNTLSTDIPFQLSKYVDN</LinearSequence>
                        <StartingPosition>841</StartingPosition>
                        <EndingPosition>859</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>70140</EpitopeId>
                <ReferenceStartingPosition>841</ReferenceStartingPosition>
                <ReferenceEndingPosition>859</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>22825</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N29</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>VNNTLSTDIPFQLSKYVDN</LinearSequence>
                                        <StartingPosition>841</StartingPosition>
                                        <EndingPosition>859</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>22828</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N29</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>VNNTLSTDIPFQLSKYVDN</LinearSequence>
                                        <StartingPosition>841</StartingPosition>
                                        <EndingPosition>859</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>22827</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N29</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>VNNTLSTDIPFQLSKYVDN</LinearSequence>
                                        <StartingPosition>841</StartingPosition>
                                        <EndingPosition>859</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>22826</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>N29</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>VNNTLSTDIPFQLSKYVDN</LinearSequence>
                                        <StartingPosition>841</StartingPosition>
                                        <EndingPosition>859</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>C1</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KYVDNQRLLSTFTEYIKNI</LinearSequence>
                        <StartingPosition>855</StartingPosition>
                        <EndingPosition>873</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>34621</EpitopeId>
                <ReferenceStartingPosition>855</ReferenceStartingPosition>
                <ReferenceEndingPosition>873</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>22833</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C1</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KYVDNQRLLSTFTEYIKNI</LinearSequence>
                                        <StartingPosition>855</StartingPosition>
                                        <EndingPosition>873</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>22835</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>3000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C1</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KYVDNQRLLSTFTEYIKNI</LinearSequence>
                                        <StartingPosition>855</StartingPosition>
                                        <EndingPosition>873</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>22836</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C1</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KYVDNQRLLSTFTEYIKNI</LinearSequence>
                                        <StartingPosition>855</StartingPosition>
                                        <EndingPosition>873</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>22834</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>25000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C1</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KYVDNQRLLSTFTEYIKNI</LinearSequence>
                                        <StartingPosition>855</StartingPosition>
                                        <EndingPosition>873</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>C2</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>YIKNIINTSILNLRYESNH</LinearSequence>
                        <StartingPosition>869</StartingPosition>
                        <EndingPosition>887</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>74279</EpitopeId>
                <ReferenceStartingPosition>869</ReferenceStartingPosition>
                <ReferenceEndingPosition>887</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>22840</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>25000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C2</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YIKNIINTSILNLRYESNH</LinearSequence>
                                        <StartingPosition>869</StartingPosition>
                                        <EndingPosition>887</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>22837</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>25000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C2</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YIKNIINTSILNLRYESNH</LinearSequence>
                                        <StartingPosition>869</StartingPosition>
                                        <EndingPosition>887</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>22839</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>25000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C2</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YIKNIINTSILNLRYESNH</LinearSequence>
                                        <StartingPosition>869</StartingPosition>
                                        <EndingPosition>887</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>22838</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C2</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YIKNIINTSILNLRYESNH</LinearSequence>
                                        <StartingPosition>869</StartingPosition>
                                        <EndingPosition>887</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>C3</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>YESNHLIDLSRYASKINIG</LinearSequence>
                        <StartingPosition>883</StartingPosition>
                        <EndingPosition>901</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>73763</EpitopeId>
                <ReferenceStartingPosition>883</ReferenceStartingPosition>
                <ReferenceEndingPosition>901</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>22844</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>35000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C3</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YESNHLIDLSRYASKINIG</LinearSequence>
                                        <StartingPosition>883</StartingPosition>
                                        <EndingPosition>901</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>22843</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C3</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YESNHLIDLSRYASKINIG</LinearSequence>
                                        <StartingPosition>883</StartingPosition>
                                        <EndingPosition>901</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>22842</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C3</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YESNHLIDLSRYASKINIG</LinearSequence>
                                        <StartingPosition>883</StartingPosition>
                                        <EndingPosition>901</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>22841</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C3</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YESNHLIDLSRYASKINIG</LinearSequence>
                                        <StartingPosition>883</StartingPosition>
                                        <EndingPosition>901</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>C4</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KINIGSKVNFDPIDKNQIQ</LinearSequence>
                        <StartingPosition>897</StartingPosition>
                        <EndingPosition>915</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>31365</EpitopeId>
                <ReferenceStartingPosition>897</ReferenceStartingPosition>
                <ReferenceEndingPosition>915</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>22845</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C4</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KINIGSKVNFDPIDKNQIQ</LinearSequence>
                                        <StartingPosition>897</StartingPosition>
                                        <EndingPosition>915</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>22848</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>3000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C4</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KINIGSKVNFDPIDKNQIQ</LinearSequence>
                                        <StartingPosition>897</StartingPosition>
                                        <EndingPosition>915</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>22846</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>3000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C4</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KINIGSKVNFDPIDKNQIQ</LinearSequence>
                                        <StartingPosition>897</StartingPosition>
                                        <EndingPosition>915</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>22847</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C4</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KINIGSKVNFDPIDKNQIQ</LinearSequence>
                                        <StartingPosition>897</StartingPosition>
                                        <EndingPosition>915</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>C5</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KNQIQLFNLESSKIEVILK</LinearSequence>
                        <StartingPosition>911</StartingPosition>
                        <EndingPosition>929</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>32595</EpitopeId>
                <ReferenceStartingPosition>911</ReferenceStartingPosition>
                <ReferenceEndingPosition>929</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>22849</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>15000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C5</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KNQIQLFNLESSKIEVILK</LinearSequence>
                                        <StartingPosition>911</StartingPosition>
                                        <EndingPosition>929</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>22850</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C5</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KNQIQLFNLESSKIEVILK</LinearSequence>
                                        <StartingPosition>911</StartingPosition>
                                        <EndingPosition>929</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>22851</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C5</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KNQIQLFNLESSKIEVILK</LinearSequence>
                                        <StartingPosition>911</StartingPosition>
                                        <EndingPosition>929</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>22852</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C5</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KNQIQLFNLESSKIEVILK</LinearSequence>
                                        <StartingPosition>911</StartingPosition>
                                        <EndingPosition>929</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>C6</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>EVILKNAIVYNSMYENFST</LinearSequence>
                        <StartingPosition>925</StartingPosition>
                        <EndingPosition>943</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>14730</EpitopeId>
                <ReferenceStartingPosition>925</ReferenceStartingPosition>
                <ReferenceEndingPosition>943</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>22855</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C6</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EVILKNAIVYNSMYENFST</LinearSequence>
                                        <StartingPosition>925</StartingPosition>
                                        <EndingPosition>943</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>22856</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>15000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C6</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EVILKNAIVYNSMYENFST</LinearSequence>
                                        <StartingPosition>925</StartingPosition>
                                        <EndingPosition>943</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>22854</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C6</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EVILKNAIVYNSMYENFST</LinearSequence>
                                        <StartingPosition>925</StartingPosition>
                                        <EndingPosition>943</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>22853</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>25000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C6</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EVILKNAIVYNSMYENFST</LinearSequence>
                                        <StartingPosition>925</StartingPosition>
                                        <EndingPosition>943</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>C7</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>ENFSTSFWIRIPKYFNSIS</LinearSequence>
                        <StartingPosition>939</StartingPosition>
                        <EndingPosition>957</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>13471</EpitopeId>
                <ReferenceStartingPosition>939</ReferenceStartingPosition>
                <ReferenceEndingPosition>957</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>22859</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C7</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ENFSTSFWIRIPKYFNSIS</LinearSequence>
                                        <StartingPosition>939</StartingPosition>
                                        <EndingPosition>957</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>22857</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C7</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ENFSTSFWIRIPKYFNSIS</LinearSequence>
                                        <StartingPosition>939</StartingPosition>
                                        <EndingPosition>957</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>22860</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>35000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C7</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ENFSTSFWIRIPKYFNSIS</LinearSequence>
                                        <StartingPosition>939</StartingPosition>
                                        <EndingPosition>957</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>22858</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>15000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C7</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ENFSTSFWIRIPKYFNSIS</LinearSequence>
                                        <StartingPosition>939</StartingPosition>
                                        <EndingPosition>957</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>C8</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>FNSISLNNEYTIINCMENN</LinearSequence>
                        <StartingPosition>953</StartingPosition>
                        <EndingPosition>971</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>17234</EpitopeId>
                <ReferenceStartingPosition>953</ReferenceStartingPosition>
                <ReferenceEndingPosition>971</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>22862</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C8</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>FNSISLNNEYTIINCMENN</LinearSequence>
                                        <StartingPosition>953</StartingPosition>
                                        <EndingPosition>971</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>22863</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C8</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>FNSISLNNEYTIINCMENN</LinearSequence>
                                        <StartingPosition>953</StartingPosition>
                                        <EndingPosition>971</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>22864</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C8</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>FNSISLNNEYTIINCMENN</LinearSequence>
                                        <StartingPosition>953</StartingPosition>
                                        <EndingPosition>971</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>22861</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C8</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>FNSISLNNEYTIINCMENN</LinearSequence>
                                        <StartingPosition>953</StartingPosition>
                                        <EndingPosition>971</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>C9</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>CMENNSGWKVSLNYGEIIW</LinearSequence>
                        <StartingPosition>967</StartingPosition>
                        <EndingPosition>985</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>6650</EpitopeId>
                <ReferenceStartingPosition>967</ReferenceStartingPosition>
                <ReferenceEndingPosition>985</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>22867</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>3000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C9</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>CMENNSGWKVSLNYGEIIW</LinearSequence>
                                        <StartingPosition>967</StartingPosition>
                                        <EndingPosition>985</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>22865</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C9</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>CMENNSGWKVSLNYGEIIW</LinearSequence>
                                        <StartingPosition>967</StartingPosition>
                                        <EndingPosition>985</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>22868</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>35000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C9</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>CMENNSGWKVSLNYGEIIW</LinearSequence>
                                        <StartingPosition>967</StartingPosition>
                                        <EndingPosition>985</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>22866</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C9</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>CMENNSGWKVSLNYGEIIW</LinearSequence>
                                        <StartingPosition>967</StartingPosition>
                                        <EndingPosition>985</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>C10</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GEIIWTLQDTQEIKQRVVF</LinearSequence>
                        <StartingPosition>981</StartingPosition>
                        <EndingPosition>999</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>19297</EpitopeId>
                <ReferenceStartingPosition>981</ReferenceStartingPosition>
                <ReferenceEndingPosition>999</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>22870</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>3000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C10</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GEIIWTLQDTQEIKQRVVF</LinearSequence>
                                        <StartingPosition>981</StartingPosition>
                                        <EndingPosition>999</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>22871</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C10</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GEIIWTLQDTQEIKQRVVF</LinearSequence>
                                        <StartingPosition>981</StartingPosition>
                                        <EndingPosition>999</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>22872</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>35000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C10</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GEIIWTLQDTQEIKQRVVF</LinearSequence>
                                        <StartingPosition>981</StartingPosition>
                                        <EndingPosition>999</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>22869</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>25000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C10</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GEIIWTLQDTQEIKQRVVF</LinearSequence>
                                        <StartingPosition>981</StartingPosition>
                                        <EndingPosition>999</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>C11</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>QRVVFKYSQMINISDYINR</LinearSequence>
                        <StartingPosition>995</StartingPosition>
                        <EndingPosition>1013</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>52274</EpitopeId>
                <ReferenceStartingPosition>995</ReferenceStartingPosition>
                <ReferenceEndingPosition>1013</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>22876</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>35000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C11</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>QRVVFKYSQMINISDYINR</LinearSequence>
                                        <StartingPosition>995</StartingPosition>
                                        <EndingPosition>1013</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>22875</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C11</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>QRVVFKYSQMINISDYINR</LinearSequence>
                                        <StartingPosition>995</StartingPosition>
                                        <EndingPosition>1013</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>22874</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C11</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>QRVVFKYSQMINISDYINR</LinearSequence>
                                        <StartingPosition>995</StartingPosition>
                                        <EndingPosition>1013</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>22873</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>35000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C11</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>QRVVFKYSQMINISDYINR</LinearSequence>
                                        <StartingPosition>995</StartingPosition>
                                        <EndingPosition>1013</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>C12</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>DYINRWIFVTITNNRLNNS</LinearSequence>
                        <StartingPosition>1009</StartingPosition>
                        <EndingPosition>1027</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>10902</EpitopeId>
                <ReferenceStartingPosition>1009</ReferenceStartingPosition>
                <ReferenceEndingPosition>1027</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>22877</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C12</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>DYINRWIFVTITNNRLNNS</LinearSequence>
                                        <StartingPosition>1009</StartingPosition>
                                        <EndingPosition>1027</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>22878</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C12</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>DYINRWIFVTITNNRLNNS</LinearSequence>
                                        <StartingPosition>1009</StartingPosition>
                                        <EndingPosition>1027</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>22879</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C12</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>DYINRWIFVTITNNRLNNS</LinearSequence>
                                        <StartingPosition>1009</StartingPosition>
                                        <EndingPosition>1027</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>22880</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C12</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>DYINRWIFVTITNNRLNNS</LinearSequence>
                                        <StartingPosition>1009</StartingPosition>
                                        <EndingPosition>1027</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>C13</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>RLNNSKIYINGRLIDQKPI</LinearSequence>
                        <StartingPosition>1023</StartingPosition>
                        <EndingPosition>1041</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>54688</EpitopeId>
                <ReferenceStartingPosition>1023</ReferenceStartingPosition>
                <ReferenceEndingPosition>1041</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>22882</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C13</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>RLNNSKIYINGRLIDQKPI</LinearSequence>
                                        <StartingPosition>1023</StartingPosition>
                                        <EndingPosition>1041</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>22884</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C13</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>RLNNSKIYINGRLIDQKPI</LinearSequence>
                                        <StartingPosition>1023</StartingPosition>
                                        <EndingPosition>1041</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>22881</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C13</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>RLNNSKIYINGRLIDQKPI</LinearSequence>
                                        <StartingPosition>1023</StartingPosition>
                                        <EndingPosition>1041</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>22883</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C13</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>RLNNSKIYINGRLIDQKPI</LinearSequence>
                                        <StartingPosition>1023</StartingPosition>
                                        <EndingPosition>1041</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>C14</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>DQKPISNLGNIHASNNIMF</LinearSequence>
                        <StartingPosition>1037</StartingPosition>
                        <EndingPosition>1055</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>9863</EpitopeId>
                <ReferenceStartingPosition>1037</ReferenceStartingPosition>
                <ReferenceEndingPosition>1055</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>22888</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C14</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>DQKPISNLGNIHASNNIMF</LinearSequence>
                                        <StartingPosition>1037</StartingPosition>
                                        <EndingPosition>1055</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>22886</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C14</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>DQKPISNLGNIHASNNIMF</LinearSequence>
                                        <StartingPosition>1037</StartingPosition>
                                        <EndingPosition>1055</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>22885</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C14</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>DQKPISNLGNIHASNNIMF</LinearSequence>
                                        <StartingPosition>1037</StartingPosition>
                                        <EndingPosition>1055</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>22887</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C14</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>DQKPISNLGNIHASNNIMF</LinearSequence>
                                        <StartingPosition>1037</StartingPosition>
                                        <EndingPosition>1055</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>C15</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>NNIMFKLDGCRDTHRYIWI</LinearSequence>
                        <StartingPosition>1051</StartingPosition>
                        <EndingPosition>1069</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>45130</EpitopeId>
                <ReferenceStartingPosition>1051</ReferenceStartingPosition>
                <ReferenceEndingPosition>1069</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>22892</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>35000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C15</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NNIMFKLDGCRDTHRYIWI</LinearSequence>
                                        <StartingPosition>1051</StartingPosition>
                                        <EndingPosition>1069</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>22889</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>35000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C15</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NNIMFKLDGCRDTHRYIWI</LinearSequence>
                                        <StartingPosition>1051</StartingPosition>
                                        <EndingPosition>1069</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>22891</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>15000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C15</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NNIMFKLDGCRDTHRYIWI</LinearSequence>
                                        <StartingPosition>1051</StartingPosition>
                                        <EndingPosition>1069</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>22890</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>3000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C15</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NNIMFKLDGCRDTHRYIWI</LinearSequence>
                                        <StartingPosition>1051</StartingPosition>
                                        <EndingPosition>1069</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>C16</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>RYIWIKYFNLFDKELNEKE</LinearSequence>
                        <StartingPosition>1065</StartingPosition>
                        <EndingPosition>1083</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>56557</EpitopeId>
                <ReferenceStartingPosition>1065</ReferenceStartingPosition>
                <ReferenceEndingPosition>1083</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>22895</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C16</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>RYIWIKYFNLFDKELNEKE</LinearSequence>
                                        <StartingPosition>1065</StartingPosition>
                                        <EndingPosition>1083</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>22896</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C16</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>RYIWIKYFNLFDKELNEKE</LinearSequence>
                                        <StartingPosition>1065</StartingPosition>
                                        <EndingPosition>1083</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>22894</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C16</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>RYIWIKYFNLFDKELNEKE</LinearSequence>
                                        <StartingPosition>1065</StartingPosition>
                                        <EndingPosition>1083</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>22893</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C16</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>RYIWIKYFNLFDKELNEKE</LinearSequence>
                                        <StartingPosition>1065</StartingPosition>
                                        <EndingPosition>1083</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>C17</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LNEKEIKDLYDNQSNSGIL</LinearSequence>
                        <StartingPosition>1079</StartingPosition>
                        <EndingPosition>1097</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>38203</EpitopeId>
                <ReferenceStartingPosition>1079</ReferenceStartingPosition>
                <ReferenceEndingPosition>1097</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>22897</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C17</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LNEKEIKDLYDNQSNSGIL</LinearSequence>
                                        <StartingPosition>1079</StartingPosition>
                                        <EndingPosition>1097</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>22898</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C17</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LNEKEIKDLYDNQSNSGIL</LinearSequence>
                                        <StartingPosition>1079</StartingPosition>
                                        <EndingPosition>1097</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>22899</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C17</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LNEKEIKDLYDNQSNSGIL</LinearSequence>
                                        <StartingPosition>1079</StartingPosition>
                                        <EndingPosition>1097</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>22900</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C17</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LNEKEIKDLYDNQSNSGIL</LinearSequence>
                                        <StartingPosition>1079</StartingPosition>
                                        <EndingPosition>1097</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>C18</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>NSGILKDFWGDYLQYDKPY</LinearSequence>
                        <StartingPosition>1093</StartingPosition>
                        <EndingPosition>1111</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>45824</EpitopeId>
                <ReferenceStartingPosition>1093</ReferenceStartingPosition>
                <ReferenceEndingPosition>1111</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>22901</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C18</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NSGILKDFWGDYLQYDKPY</LinearSequence>
                                        <StartingPosition>1093</StartingPosition>
                                        <EndingPosition>1111</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>22903</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C18</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NSGILKDFWGDYLQYDKPY</LinearSequence>
                                        <StartingPosition>1093</StartingPosition>
                                        <EndingPosition>1111</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>22904</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>15000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C18</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NSGILKDFWGDYLQYDKPY</LinearSequence>
                                        <StartingPosition>1093</StartingPosition>
                                        <EndingPosition>1111</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>22902</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C18</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NSGILKDFWGDYLQYDKPY</LinearSequence>
                                        <StartingPosition>1093</StartingPosition>
                                        <EndingPosition>1111</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>C19</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>YDKPYYMLNLYDPNKYVDV</LinearSequence>
                        <StartingPosition>1107</StartingPosition>
                        <EndingPosition>1125</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>73554</EpitopeId>
                <ReferenceStartingPosition>1107</ReferenceStartingPosition>
                <ReferenceEndingPosition>1125</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>22908</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C19</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YDKPYYMLNLYDPNKYVDV</LinearSequence>
                                        <StartingPosition>1107</StartingPosition>
                                        <EndingPosition>1125</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>22907</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C19</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YDKPYYMLNLYDPNKYVDV</LinearSequence>
                                        <StartingPosition>1107</StartingPosition>
                                        <EndingPosition>1125</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>22905</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>3000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C19</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YDKPYYMLNLYDPNKYVDV</LinearSequence>
                                        <StartingPosition>1107</StartingPosition>
                                        <EndingPosition>1125</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>22906</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C19</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YDKPYYMLNLYDPNKYVDV</LinearSequence>
                                        <StartingPosition>1107</StartingPosition>
                                        <EndingPosition>1125</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>C20</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KYVDVNNVGIRGYMYLKGP</LinearSequence>
                        <StartingPosition>1121</StartingPosition>
                        <EndingPosition>1139</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>34622</EpitopeId>
                <ReferenceStartingPosition>1121</ReferenceStartingPosition>
                <ReferenceEndingPosition>1139</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>22911</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>3000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C20</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KYVDVNNVGIRGYMYLKGP</LinearSequence>
                                        <StartingPosition>1121</StartingPosition>
                                        <EndingPosition>1139</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>22912</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>35000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C20</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KYVDVNNVGIRGYMYLKGP</LinearSequence>
                                        <StartingPosition>1121</StartingPosition>
                                        <EndingPosition>1139</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>22910</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C20</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KYVDVNNVGIRGYMYLKGP</LinearSequence>
                                        <StartingPosition>1121</StartingPosition>
                                        <EndingPosition>1139</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>22909</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C20</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KYVDVNNVGIRGYMYLKGP</LinearSequence>
                                        <StartingPosition>1121</StartingPosition>
                                        <EndingPosition>1139</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>C21</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>YLKGPRGSVMTTNIYLNSS</LinearSequence>
                        <StartingPosition>1135</StartingPosition>
                        <EndingPosition>1153</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>74737</EpitopeId>
                <ReferenceStartingPosition>1135</ReferenceStartingPosition>
                <ReferenceEndingPosition>1153</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>22914</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>3000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C21</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YLKGPRGSVMTTNIYLNSS</LinearSequence>
                                        <StartingPosition>1135</StartingPosition>
                                        <EndingPosition>1153</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>22913</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>15000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C21</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YLKGPRGSVMTTNIYLNSS</LinearSequence>
                                        <StartingPosition>1135</StartingPosition>
                                        <EndingPosition>1153</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>22915</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>3000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C21</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YLKGPRGSVMTTNIYLNSS</LinearSequence>
                                        <StartingPosition>1135</StartingPosition>
                                        <EndingPosition>1153</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>22916</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>25000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C21</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YLKGPRGSVMTTNIYLNSS</LinearSequence>
                                        <StartingPosition>1135</StartingPosition>
                                        <EndingPosition>1153</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>C22</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>YLNSSLYRGTKFIIKKYAS</LinearSequence>
                        <StartingPosition>1149</StartingPosition>
                        <EndingPosition>1167</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>74849</EpitopeId>
                <ReferenceStartingPosition>1149</ReferenceStartingPosition>
                <ReferenceEndingPosition>1167</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>22917</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>3000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C22</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YLNSSLYRGTKFIIKKYAS</LinearSequence>
                                        <StartingPosition>1149</StartingPosition>
                                        <EndingPosition>1167</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>22920</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>15000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C22</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YLNSSLYRGTKFIIKKYAS</LinearSequence>
                                        <StartingPosition>1149</StartingPosition>
                                        <EndingPosition>1167</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>22918</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C22</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YLNSSLYRGTKFIIKKYAS</LinearSequence>
                                        <StartingPosition>1149</StartingPosition>
                                        <EndingPosition>1167</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>22919</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C22</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YLNSSLYRGTKFIIKKYAS</LinearSequence>
                                        <StartingPosition>1149</StartingPosition>
                                        <EndingPosition>1167</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>C23</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KKYASGNKDNIVRNNDRVY</LinearSequence>
                        <StartingPosition>1163</StartingPosition>
                        <EndingPosition>1181</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>31736</EpitopeId>
                <ReferenceStartingPosition>1163</ReferenceStartingPosition>
                <ReferenceEndingPosition>1181</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>22922</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C23</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KKYASGNKDNIVRNNDRVY</LinearSequence>
                                        <StartingPosition>1163</StartingPosition>
                                        <EndingPosition>1181</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>22921</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>3000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C23</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KKYASGNKDNIVRNNDRVY</LinearSequence>
                                        <StartingPosition>1163</StartingPosition>
                                        <EndingPosition>1181</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>22923</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C23</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KKYASGNKDNIVRNNDRVY</LinearSequence>
                                        <StartingPosition>1163</StartingPosition>
                                        <EndingPosition>1181</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>22924</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C23</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KKYASGNKDNIVRNNDRVY</LinearSequence>
                                        <StartingPosition>1163</StartingPosition>
                                        <EndingPosition>1181</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>C24</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>NDRVYINVVVKNKEYRLAT</LinearSequence>
                        <StartingPosition>1177</StartingPosition>
                        <EndingPosition>1195</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>43525</EpitopeId>
                <ReferenceStartingPosition>1177</ReferenceStartingPosition>
                <ReferenceEndingPosition>1195</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>22928</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>35000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C24</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NDRVYINVVVKNKEYRLAT</LinearSequence>
                                        <StartingPosition>1177</StartingPosition>
                                        <EndingPosition>1195</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>22925</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>25000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C24</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NDRVYINVVVKNKEYRLAT</LinearSequence>
                                        <StartingPosition>1177</StartingPosition>
                                        <EndingPosition>1195</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>22927</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>15000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C24</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NDRVYINVVVKNKEYRLAT</LinearSequence>
                                        <StartingPosition>1177</StartingPosition>
                                        <EndingPosition>1195</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>22926</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C24</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NDRVYINVVVKNKEYRLAT</LinearSequence>
                                        <StartingPosition>1177</StartingPosition>
                                        <EndingPosition>1195</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>C25</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>YRLATNASQAGVEKILSAL</LinearSequence>
                        <StartingPosition>1191</StartingPosition>
                        <EndingPosition>1209</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>75629</EpitopeId>
                <ReferenceStartingPosition>1191</ReferenceStartingPosition>
                <ReferenceEndingPosition>1209</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>22929</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>3000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C25</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YRLATNASQAGVEKILSAL</LinearSequence>
                                        <StartingPosition>1191</StartingPosition>
                                        <EndingPosition>1209</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>22930</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>15000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C25</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YRLATNASQAGVEKILSAL</LinearSequence>
                                        <StartingPosition>1191</StartingPosition>
                                        <EndingPosition>1209</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>22931</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C25</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YRLATNASQAGVEKILSAL</LinearSequence>
                                        <StartingPosition>1191</StartingPosition>
                                        <EndingPosition>1209</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>22932</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C25</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YRLATNASQAGVEKILSAL</LinearSequence>
                                        <StartingPosition>1191</StartingPosition>
                                        <EndingPosition>1209</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>C26</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>ILSALEIPDVGNLSQVVVM</LinearSequence>
                        <StartingPosition>1205</StartingPosition>
                        <EndingPosition>1223</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>27308</EpitopeId>
                <ReferenceStartingPosition>1205</ReferenceStartingPosition>
                <ReferenceEndingPosition>1223</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>22933</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C26</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ILSALEIPDVGNLSQVVVM</LinearSequence>
                                        <StartingPosition>1205</StartingPosition>
                                        <EndingPosition>1223</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>22935</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C26</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ILSALEIPDVGNLSQVVVM</LinearSequence>
                                        <StartingPosition>1205</StartingPosition>
                                        <EndingPosition>1223</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>22936</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C26</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ILSALEIPDVGNLSQVVVM</LinearSequence>
                                        <StartingPosition>1205</StartingPosition>
                                        <EndingPosition>1223</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>22934</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C26</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ILSALEIPDVGNLSQVVVM</LinearSequence>
                                        <StartingPosition>1205</StartingPosition>
                                        <EndingPosition>1223</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>C27</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>QVVVMKSKNDQGITNKCKM</LinearSequence>
                        <StartingPosition>1219</StartingPosition>
                        <EndingPosition>1237</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>52813</EpitopeId>
                <ReferenceStartingPosition>1219</ReferenceStartingPosition>
                <ReferenceEndingPosition>1237</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>22937</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C27</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>QVVVMKSKNDQGITNKCKM</LinearSequence>
                                        <StartingPosition>1219</StartingPosition>
                                        <EndingPosition>1237</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>22940</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C27</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>QVVVMKSKNDQGITNKCKM</LinearSequence>
                                        <StartingPosition>1219</StartingPosition>
                                        <EndingPosition>1237</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>22938</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C27</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>QVVVMKSKNDQGITNKCKM</LinearSequence>
                                        <StartingPosition>1219</StartingPosition>
                                        <EndingPosition>1237</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>22939</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C27</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>QVVVMKSKNDQGITNKCKM</LinearSequence>
                                        <StartingPosition>1219</StartingPosition>
                                        <EndingPosition>1237</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>C28</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>NKCKMNLQDNNGNDIGFIG</LinearSequence>
                        <StartingPosition>1233</StartingPosition>
                        <EndingPosition>1251</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>44468</EpitopeId>
                <ReferenceStartingPosition>1233</ReferenceStartingPosition>
                <ReferenceEndingPosition>1251</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>22942</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C28</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NKCKMNLQDNNGNDIGFIG</LinearSequence>
                                        <StartingPosition>1233</StartingPosition>
                                        <EndingPosition>1251</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>22941</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C28</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NKCKMNLQDNNGNDIGFIG</LinearSequence>
                                        <StartingPosition>1233</StartingPosition>
                                        <EndingPosition>1251</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>22943</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C28</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NKCKMNLQDNNGNDIGFIG</LinearSequence>
                                        <StartingPosition>1233</StartingPosition>
                                        <EndingPosition>1251</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>22944</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C28</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NKCKMNLQDNNGNDIGFIG</LinearSequence>
                                        <StartingPosition>1233</StartingPosition>
                                        <EndingPosition>1251</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>C29</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>IGFIGFHQFNNIAKLVASN</LinearSequence>
                        <StartingPosition>1247</StartingPosition>
                        <EndingPosition>1265</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>26220</EpitopeId>
                <ReferenceStartingPosition>1247</ReferenceStartingPosition>
                <ReferenceEndingPosition>1265</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>22945</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>15000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C29</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>IGFIGFHQFNNIAKLVASN</LinearSequence>
                                        <StartingPosition>1247</StartingPosition>
                                        <EndingPosition>1265</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>22946</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>3000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C29</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>IGFIGFHQFNNIAKLVASN</LinearSequence>
                                        <StartingPosition>1247</StartingPosition>
                                        <EndingPosition>1265</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>22947</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C29</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>IGFIGFHQFNNIAKLVASN</LinearSequence>
                                        <StartingPosition>1247</StartingPosition>
                                        <EndingPosition>1265</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>22948</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>3000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C29</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>IGFIGFHQFNNIAKLVASN</LinearSequence>
                                        <StartingPosition>1247</StartingPosition>
                                        <EndingPosition>1265</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>C30</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LVASNWYNRQIERSSRTLG</LinearSequence>
                        <StartingPosition>1261</StartingPosition>
                        <EndingPosition>1279</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>40281</EpitopeId>
                <ReferenceStartingPosition>1261</ReferenceStartingPosition>
                <ReferenceEndingPosition>1279</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>22949</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>7000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C30</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LVASNWYNRQIERSSRTLG</LinearSequence>
                                        <StartingPosition>1261</StartingPosition>
                                        <EndingPosition>1279</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>22952</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>25000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C30</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LVASNWYNRQIERSSRTLG</LinearSequence>
                                        <StartingPosition>1261</StartingPosition>
                                        <EndingPosition>1279</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>22951</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C30</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LVASNWYNRQIERSSRTLG</LinearSequence>
                                        <StartingPosition>1261</StartingPosition>
                                        <EndingPosition>1279</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>22950</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>15000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C30</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LVASNWYNRQIERSSRTLG</LinearSequence>
                                        <StartingPosition>1261</StartingPosition>
                                        <EndingPosition>1279</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>C31</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SRTLGCSWEFIPVDDGWGERPL</LinearSequence>
                        <StartingPosition>1275</StartingPosition>
                        <EndingPosition>1296</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P10845.4</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1491</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>60819</EpitopeId>
                <ReferenceStartingPosition>1275</ReferenceStartingPosition>
                <ReferenceEndingPosition>1296</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 1</LocationOfData>
                        <BCellId>22953</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>15000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C31</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SRTLGCSWEFIPVDDGWGERPL</LinearSequence>
                                        <StartingPosition>1275</StartingPosition>
                                        <EndingPosition>1296</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 4</LocationOfData>
                        <BCellId>22956</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9031</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Chicken antisera were made by monthly subcutaneous injections of formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera used in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>25000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C31</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SRTLGCSWEFIPVDDGWGERPL</LinearSequence>
                                        <StartingPosition>1275</StartingPosition>
                                        <EndingPosition>1296</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 2</LocationOfData>
                        <BCellId>22954</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>BoNT/A toxoid</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Ribi</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Horse antisera were prepared by subcutaneous immunization, in multiple sites every 2 weeks for over a year, with a formaldehyde-inactivated botulinum neurotoxin A (BoNT/A) in Ribi adjuvant. The antisera tested in the binding studies were obtained after 4 injections and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>25000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C31</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SRTLGCSWEFIPVDDGWGERPL</LinearSequence>
                                        <StartingPosition>1275</StartingPosition>
                                        <EndingPosition>1296</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2, Figure 3</LocationOfData>
                        <BCellId>22955</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P10845.4</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1491</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>pentavalent toxoid (botulinum neurotoxins A, B, C, D and E)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Outbred (ICR) mice were immunized subcutaneously with the pentavalent toxoid. The antisera used for the studies were obtained 91 days after the first injection and pooled from a number of animals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>15000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&lt;</MeasurementInequality>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>C31</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SRTLGCSWEFIPVDDGWGERPL</LinearSequence>
                                        <StartingPosition>1275</StartingPosition>
                                        <EndingPosition>1296</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P10845.4</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1491</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

